Loading...

About Us

Detavax Biotech is a privately-held company, dedicated to identifying, developing, manufacturing, and commercializing innovative therapeutic vaccines for the treatment of infectious diseases and cancer with major unmet needs, these vaccines are accurate and simple in design, targets specific and their reduced manufacturing costs are un matched by current technologies. Furthermore, we provide Sequencing service and assay development services to both national and international clients. Detavax Biotech team is comprised of experienced researchers with extensive bioinformatics knowledge. In order to optimize your results, our services are tailored specifically to your needs. Our aim is to provide the best service and products specifically for the Pharma-biotech sector, researchers, especially in the field of a peptide-based vaccine. we welcome the opportunity to cooperate with any company and look forwards to any fruitful collaboration.

DetaVax Biotech DNA Technologies & Expression Analysis Core

Our Technology

DetaVax Biotech Vaccine Designing and development Core facility




Company History

Detavax Biotech was founded in 2019 by researchers working in the Detagen Genetic diagnostics center which has years of experience in genetics diagnostics developing and biotech fields. DetaGen is a leading private diagnostics and research institution hub located at Kayseri city(Turkey) our research genetics diagnostic and research center is shown to have top quality and major impact on society and the economy with respect to several genetics testing services and facilities, Since the foundation Detavax, there have been important advances on the candidate’s research, legal contracts, patents registration, business networking, and financial matters.

  • Our Mantra
  • Develop Definitive Cures and Provide Effective Prevention for Infectious Diseases and Cancer

  • Our Vision
  • Committed to saving human and animal lives by unlocking new Unlocking New Ways to treat Disease and Cancer

Board and manage Team

Technology

DetaVax Biotech is led by a highly Committed, dynamic and versatile Board and Management team with a wealth of experience and an impressive track record of scientific research, and product commercialization in the Biotechnology, Pharmaceutical industry.

Doctor Team

Image

Mohammedahmed Hassan

Dr.
Image

Abdulhakim COŞKUN

Prof.Dr.
Image

Fatma DEMİRYILMAZ

Uzm.Dr.

How It Works

Lorem ipsum dolor, sit amet consectetur adipisicing elit. Voluptas fugiat molestiae eligendi repudiandae error?

Partnership for Success

Technology

Detavax Biotech Peptide based approach therapy platform can be applied to multiple indications including viruses, bacteria, and cancer and has advantages of mass production without pathogen contamination, high safety owing to no nucleic acid involvement, easy synthesis, low cost, and increased stability. The synthetic peptide vaccine is the most ideal new safe vaccine, and it is also one of the main directions for the development of new vaccines for the prevention and control of infectious diseases and cancer, our industry and business strategy is to creatively partner key resources and expertise through various partnering models to maximize the therapeutic potentials of our technologies and products. All Detavax vaccine trials will be conducted by Turkish, China and U.S.-based contract research organizations under good clinical practices (GCP).

R&D

We are currently focusing on the development of our Whites Spot virus vaccine, as well as our first Mycetoma therapeutic vaccine

Investors

Investment opportunities We truly believe that The best way to discuss your ideas and opportunities is to meet in person. Investors interested to learn more about investing in Detavax Biotech are welcome to contact us. Please send enquiries to info@detavax.com Alternatively, you can meet us at the following upcoming conferences

R&D

We are currently focusing on the development of our Whites Spot virus vaccine, as well as our first Mycetoma therapeutic vaccine

Learn More

Investors

Investment opportunities We truly believe that The best way to discuss your ideas and opportunities is to meet in person. Investors interested to learn more about investing in Detavax Biotech are welcome to contact us. Please send enquiries to info@detavax.com Alternatively, you can meet us at the following upcoming conferences

Learn More

Career Opportunities

Detavax Career

Working at DetaVaX Are you a talented, passionate and committed team player whose scientific curiosity is complemented by an entrepreneurial spirit? Do you feel motivated to bring innovative diagnostics and therapeutic solutions to breakthrough?
If so, we encourage you to send your curriculum vitae to info@detavax.com
We will contact you if anything suitable arises.

Contact Us

Erciyes Üniversitesi Teknoloji Geliştirme Bölgesi İdare ve Kuluçka Merkezi 4.Binası Dış Kapı:67/3 İç Kapı:51 38030 Melikgazi /KAYSERİ

Detavax Biotech is a privately-held company, dedicated to identifying, developing, manufacturing, and commercializing innovative therapeutic vaccines for the treatment of infectious diseases and cancer with major unmet needs, these vaccines are accurate and simple in design, targets specific and their reduced manufacturing costs are un matched by current technologies. Furthermore, we provide Sequencing service and assay development services to both national and international clients. Detavax Biotech team is comprised of experienced researchers with extensive bioinformatics knowledge. In order to optimize your results, our services are tailored specifically to your needs.